| 1 |
35122700 | Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. | 2022 May |
1 |
| 2 |
34681173 | Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells. | 2021 Sep 22 |
1 |
| 3 |
27196755 | Loss of PKCδ Induces Prostate Cancer Resistance to Paclitaxel through Activation of Wnt/β-Catenin Pathway and Mcl-1 Accumulation. | 2016 Jul |
1 |
| 4 |
23408298 | A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. | 2013 May 15 |
1 |
| 5 |
23535839 | Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer. | 2013 Apr |
2 |
| 6 |
24062525 | Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. | 2013 Oct 2 |
2 |
| 7 |
22487539 | Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. | 2012 Jul |
1 |
| 8 |
22895534 | Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer. | 2012 Oct |
1 |
| 9 |
19240722 | The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. | 2009 Mar 24 |
1 |
| 10 |
17036319 | Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231). | 2007 Jan 1 |
2 |